GCP
DRTSW icon

Gill Capital Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Gill Capital Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Hold
500
– – ﹤0.01% 593
2026
Q1 		$500 Buy
+500
New +$481 ﹤0.01% 634

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Gill Capital Partners's DRTSW Position: Q2 2026 in Review

Gill Capital Partners held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2026 at 500 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Gill Capital Partners first reported a position in DRTSW in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Gill Capital Partners held 500 shares of Alpha Tau Medical Warrant worth $1.48K as of Q2 2026.
  • Gill Capital Partners left its Alpha Tau Medical Warrant share count unchanged in Q2 2026.
  • Alpha Tau Medical Warrant made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #593 holding.
  • Gill Capital Partners first reported a position in Alpha Tau Medical Warrant in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.